Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 9241 AL 9255

Cognitive training for Alzheimer's disease and other forms of dementia: Insights from a systematic review and Bayesian meta-analysis

Giaquinto F, Iaia M, Rizzi E, Macchitella L, Romano DL, Tosi G, Angelelli P.

J Alzheimers Dis. 2025 Jun;105(4):1252-1274. doi: 10.1177/13872877251334795. Epub 2025 May 13.

Exercise prescriptions for older adults with different degrees of cognitive impairment: A dose-response network meta-analysis

Zang W, Fang M, Xiao N, Wu J, Zhang Q, Mao X.

Clin Rehabil. 2026 Feb;40(2):154-170. doi: 10.1177/02692155251385219. Epub 2025 Oct 14.

Design of a Mobile App and a Clinical Trial Management System for Cognitive Health and Dementia Risk Reduction: User-Centered Design Approach

Hilberger H, Buchgraber-Schnalzer B, Huber S, Weitlaner T, Bödenler M, Abaci A, Bruinsma J, Diaz A, Guazzarini AG, Lehtisalo J, Lee S, Loukas V, Mangialasche F, Mecocci P, Ngandu T, Rosenberg A, Stögmann E, Valkonen K, Uhlik E, Untersteiner H, Kneß L, Ahammer H, Hanke S.

JMIR Aging. 2025 Jul 2;8:e66660. doi: 10.2196/66660.

Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis

Melville M, He L, Desai R, Nyamayaro P, Fox C, Kothari KU, Condron P, Miao M, Hickey M, Spector A.

Lancet Healthy Longev. 2025 Dec;6(12):100803. doi: 10.1016/j.lanhl.2025.100803. Epub 2025 Dec 22.

Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial

Han X, Gong S, Gong J, Wang P, Li R, Chen R, Xu C, Sun W, Li S, Chen Y, Yang Y, Luan H, Wen B, Guo J, Lv S, Wei C.

Psychiatry Clin Neurosci. 2025 Jun;79(6):336-343. doi: 10.1111/pcn.13812. Epub 2025 Mar 31.

Improving Early Dementia Detection Among Diverse Older Adults With Cognitive Concerns With the 5-Cog Paradigm: Protocol for a Hybrid Effectiveness-Implementation Clinical Trial

Chalmer RBR, Ayers E, Weiss EF, Fowler NR, Telzak A, Summanwar D, Zwerling J, Wang C, Xu H, Holden RJ, Fiori K, French DD, Nsubayi C, Ansari A, Dexter P, Higbie A, Yadav P, Walker JM, Congivaram H, Adhikari D, Melecio-Vazquez M, Boustani M, Verghese J.

JMIR Res Protoc. 2025 Apr 3;14:e60471. doi: 10.2196/60471.

The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease

Torre M, Zanella CA, Feany MB.

Am J Pathol. 2025 Nov;195(11):2088-2101. doi: 10.1016/j.ajpath.2024.12.013. Epub 2025 Jan 23.

Comparison of the diagnostic accuracy of five cross-cultural cognitive screening instruments for dementia and mild cognitive impairment in a multicultural memory clinic sample

Nielsen TR, Jørgensen K, Delgado-Álvarez A, Franzen S, Lozano-Ruiz A, Özden M, Palisson J, Mukadam N, Waldemar G.

J Alzheimers Dis. 2025 Aug;106(3):1143-1152. doi: 10.1177/13872877251351037. Epub 2025 Jun 22.

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease

Siemers E, Feaster T, Sethuraman G, Sundell K, Skljarevski V, Cline EN, Zhang H, Jerecic J, Honig LS, Salloway S, Sperling R, Trame MN, Dodds MG, Johnson K.

J Prev Alzheimers Dis. 2025 Jan;12(1):100005. doi: 10.1016/j.tjpad.2024.100005. Epub 2025 Jan 1.

Machine learning models for dementia screening to classify brain amyloid positivity on positron emission tomography using blood markers and demographic characteristics: a retrospective observational study

Kimura N, Sasaki K, Masuda T, Ataka T, Matsumoto M, Kitamura M, Nakamura Y, Matsubara E.

Alzheimers Res Ther. 2025 Jan 21;17(1):25. doi: 10.1186/s13195-024-01650-1.

Dialysis modality and cognitive outcomes in chronic kidney disease: a systematic review and meta-analysis

Malik A, Mansour HRK, Kundur SP, Hunjan A, Zaheer R.

Clin Exp Nephrol. 2026 Mar;30(3):408-423. doi: 10.1007/s10157-025-02798-2. Epub 2025 Dec 1.

Program of intensive support in emergency departments for care partners of cognitively impaired patients: A randomized controlled trial

Chodosh J, Fowler NR, Perkins AJ, Connor KI, Messina F, Boustani M, Borson S.

Alzheimers Dement. 2025 May;21(5):e70306. doi: 10.1002/alz.70306.

Development and validation of the Montreal Cognitive Assessment for People with Vision Impairment (MOCA-VI)

Dawes P, Reeves D, Yeung WK, Holland F, Charalambous AP, David R, Helmer C, Keay L, Kumaran S, Leighton RE, Little JA, Martins RN, Piano M, Politis A, Pye A, Robinson G, Russell G, Sheikh S, Sohrabi HR, Thodi C, Gallant K, Nasreddine Z, Leroi I.

Psychol Assess. 2025 Mar;37(3):114-122. doi: 10.1037/pas0001357.

The Microbiota-gut-brain axis in vascular cognitive impairment: unraveling the mysterious link and therapeutic prospects

Liu T, Li Y, Xiong X, Lai X, Xu X.

Front Immunol. 2025 Oct 7;16:1648800. doi: 10.3389/fimmu.2025.1648800. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias